Skip Navigation LinksHome > May 2012 - Volume 27 - Issue 3 > Contributor Index

May 2012 - Volume 27 - Issue 3 - Contributor Index

View All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Actions
View
Show
Previous of 3 Next
Author Name Article
Zhou, Weihua

Combination of citalopram plus paliperidone is better than citalopram alone in the treatment of somatoform disorder: results of a 6-week randomized study

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Xu, Yi

Combination of citalopram plus paliperidone is better than citalopram alone in the treatment of somatoform disorder: results of a 6-week randomized study

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Weizman, Abraham

Can Minnesota Multiphasic Personality Inventory-2 predict response to selective serotonin reuptake inhibitors in depressed outpatients?

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions

Antipsychotic monotherapy and adjuvant psychotropic therapies in schizophrenia patients: effect on time to readmission

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Wei, Ning

Combination of citalopram plus paliperidone is better than citalopram alone in the treatment of somatoform disorder: results of a 6-week randomized study

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Weaver, Jerry J.

Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Wang, Shanshan

Combination of citalopram plus paliperidone is better than citalopram alone in the treatment of somatoform disorder: results of a 6-week randomized study

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Valevski, Avi

Antipsychotic monotherapy and adjuvant psychotropic therapies in schizophrenia patients: effect on time to readmission

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Vainder, Michael

Can Minnesota Multiphasic Personality Inventory-2 predict response to selective serotonin reuptake inhibitors in depressed outpatients?

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Tsuchiya, Satoru

Long-term safety and tolerability of lurasidone in schizophrenia: a 12-month, double-blind, active-controlled study

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Thase, Michael E.

Efficacy of adjunctive aripiprazole in patients with major depressive disorder who showed minimal response to initial antidepressant therapy

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Silva, Robert

Long-term safety and tolerability of lurasidone in schizophrenia: a 12-month, double-blind, active-controlled study

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Shiovitz, Thomas M.

Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Sarma, Kaushik

Long-term safety and tolerability of lurasidone in schizophrenia: a 12-month, double-blind, active-controlled study

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Rollin, Linda M.

Efficacy of adjunctive aripiprazole in patients with major depressive disorder who showed minimal response to initial antidepressant therapy

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Rickels, Karl

Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Reznik, Ilya

Can Minnesota Multiphasic Personality Inventory-2 predict response to selective serotonin reuptake inhibitors in depressed outpatients?

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Ramey, Tanya S.

Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Phillips, Debra

Long-term safety and tolerability of lurasidone in schizophrenia: a 12-month, double-blind, active-controlled study

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Olfson, Mark

Antipsychotic monotherapy and adjuvant psychotropic therapies in schizophrenia patients: effect on time to readmission

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Actions
View
Show
Previous of 3 Next